Asset
COFIRASERSEN
Ionis Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04441788 | phase2 | terminated | 2020-12-22 | 2021-04-27 | Ionis Pharmaceuticals, Inc. | A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB) |
FDA applications (0)
This company has no applications containing this asset.